Citation: Ms. Benedetti et M. Bani, DESIGN OF IN-VITRO STUDIES TO PREDICT IN-VIVO INHIBITORY DRUG-DRUG INTERACTIONS, Pharmacological research, 38(2), 1998, pp. 81-88
Authors:
FORNASINI G
MONTI N
BROGIN G
GALLINA M
EANDI M
PERSIANI S
BANI M
DELLAPEPA C
ZARA G
BENEDETTI MS
Citation: G. Fornasini et al., PRELIMINARY PHARMACOKINETIC STUDY OF IBUPROFEN ENANTIOMERS AFTER ADMINISTRATION OF A NEW ORAL FORMULATION (IBUPROFEN ARGININE) TO HEALTHY MALE-VOLUNTEERS, Chirality, 9(3), 1997, pp. 297-302
Authors:
BOTTIGER Y
DOSTERT P
BENEDETTI MS
BANI M
FIORENTINI F
CASATI M
POGGESTI I
ALM C
ALVAN G
BERTILSSON L
Citation: Y. Bottiger et al., INVOLVEMENT OF CYP2D6 BUT NOT CYP2C19 IN NICERGOLINE METABOLISM IN HUMANS, British journal of clinical pharmacology, 42(6), 1996, pp. 707-711
Authors:
BANI M
BORMETTI R
CECCARELLI W
FIOCCHI R
GOBETTI M
LOMBROSO M
MAGNETTI S
OLGIATI V
PALLADINO M
VILLA M
VANOTTI E
Citation: M. Bani et al., NOVEL ARYLOXYALKYLTHIOIMIDAZOLES AS INHIBITORS OF ACYL-COA - CHOLESTERAL-O-ACYLTRANSFERASE, European journal of medicinal chemistry, 30(1), 1995, pp. 39-46
Authors:
VANOTTI E
BANI M
FAVARA D
GOBETTI M
LOMBROSO M
MAGNETTI S
OLGIATI V
PALLADINO M
TONON GC
Citation: E. Vanotti et al., 8-SUBSTITUTED PURINE DERIVATIVES - A NEW CLASS OF LIPID-LOWERING AGENTS, European journal of medicinal chemistry, 29(4), 1994, pp. 287-294